Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 35, 2024 - Issue 1
Submit an article Journal homepage
1,741
Views
0
CrossRef citations to date
0
Altmetric
Article

Evaluation of psoriasis patients with long-term topical corticosteroids for their risk of developing adrenal insufficiency, Cushing’s syndrome and osteoporosis

Betul Erdema Department of Dermatology, Van Training and Research Hospital, Van, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4781-7467
ORCID Icon,
Muzeyyen Gonulb Department of Dermatology, Ministry of Health, Ankara Etlik City Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0003-1914-2175
ORCID Icon,
Ilknur Ozturk Unsalc Department of Endocrine and Metabolic Disease, Ministry of Health, Ankara Etlik City Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0003-3999-6426
ORCID Icon &
Seyda Ozdemir Sahingozd Department of Biochemistry, Ministry of Health, Ankara Etlik City Hospital, Ankara, Turkey
Article: 2298880 | Received 14 Jul 2023, Accepted 18 Dec 2023, Published online: 29 Dec 2023

References

  • Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):1–5. doi: 10.1016/S0140-6736(14)61909-7.
  • Van de Kerkhof PN. Psoriasis. In: Bolognia JL, Schaffer JV, Cerroni L, editor. Bolognia dermatology. 4th ed. Philadelphia: Elsevier; 2017. pp. 138–160.
  • Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60(4):643–659. doi: 10.1016/j.jaad.2008.12.032.
  • Castela E, Archier E, Devaux S, et al. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy. J Eur Acad Dermatol Venereol. 2012;26(Suppl 3):47–51. doi: 10.1111/j.1468-3083.2012.04523.x.
  • Carruthers JA, August PJ, Staughton RC. Observations on the systemic effect of topical clobetasol propionate (dermovate). Br Med J. 1975;4(5990):203–204. doi: 10.1136/bmj.4.5990.203.
  • Samarasekera EJ, Sawyer L, Wonderling D, et al. Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses. Br J Dermatol. 2013;168(5):954–967. doi: 10.1111/bjd.12276.
  • Mooney E, Rademaker M, Dailey R, et al. Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement. Australas J Dermatol. 2015;56(4):241–251. doi: 10.1111/ajd.12313.
  • Hopkins RL, Leinung MC. Exogenous Cushing’s syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin North Am. 2005;34(2):371–384. doi: 10.1016/j.ecl.2005.01.013.
  • Cornell RC, Stoughton RB. Six-month controlled study of ­effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis. Br J Dermatol. 1981;105(1):91–95. doi: 10.1111/j.1365-2133.1981.tb00888.x.
  • Levin E, Gupta R, Butler D, et al. Topical steroid risk analysis: differentiating between physiologic and pathologic adrenal suppression. J Dermatolog Treat. 2014;25(6):501–506. doi: 10.3109/09546634.2013.844314.
  • Nakamura M, Abrouk M, Zhu H, et al. Update on the systemic risks of superpotent topical steroids. J Drugs Dermatol. 2017;16(7):643–648.
  • Decani S, Federighi V, Baruzzi E, et al. Iatrogenic cushing’s syndrome and topical steroid therapy: case series and review of the literature. J Dermatolog Treat. 2014;25(6):495–500. doi: 10.3109/09546634.2012.755252.
  • Huizenga NA, Koper JW, De Lange P, et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab. 1998;83(1):144–151. doi: 10.1210/jc.83.1.144.
  • Dreiher J, Weitzman D, Cohen AD. Psoriasis and osteoporosis: a sex-specific association? J Invest Dermatol. 2009;129(7):1643–1649. doi: 10.1038/jid.2008.432.
  • Keller JJ, Kang JH, Lin HC. Association between osteoporosis and psoriasis: results from the longitudinal health insurance database in Taiwan. Osteoporos Int. 2013;24(6):1835–1841. doi: 10.1007/s00198-012-2185-5.
  • Egeberg A, Schwarz P, Harsløf T, et al. Association of potent and very potent topical corticosteroids and the risk of ­osteoporosis and major osteoporotic fractures. JAMA Dermatol. 2021;157(3):275–282. doi: 10.1001/jamadermatol.2020.4968.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.